Assays NADH-ubiquinone-1 oxidoreductase and NADH-K3Fe(CN)6 oxidoreductase were measured at 30°C as described by Ragan (1976a) . NADHjuglone (5-hydroxy-1,4-naphthaquinone) oxidoreductase and NADH-menadione oxidoreductase were measured by the decrease in A340 of a solution containing 20,umol of potassium phosphate, pH8, 0.1,umol of NADH, 0.2,umol of juglone or menadione and 20,ug of Complex-I protein in a final volume of 1 ml and at 30°C. NADH oxidase and succinate oxidase were measured polarographically in a solution containing 20umol of potassium phosphate, pH8, 0.5,umol of NADH or 5,mol of potassium succinate and 1 mg of submitochondrialparticle protein in a final volume of 1 ml at 30°C. Protein was measured by the method of Lowry et al. (1951) , with bovine serum albumin [fraction V from Sigma (London) Chemical Co., Kingston-uponThames, Surrey, U.K.] as a standard. Flavin was extracted by precipitation of protein with 10 % (w/v) trichloroacetic acid, and determined in the neutralized supernatant from the dithionite-reduced-minusoxidized difference spectrum. An absorption coefficient of 98001itre-mol-h cm-' at 450nm was used (Massey & Swoboda, 1963 Inhibition by other iodonium compounds or structural analogues of diphenyleneiodonium was performed as follows. All constituents of the enzyme assay, except NADH, were incubated at 30°C with various amounts of the inhibitor for 5min before initiation of the reaction with NADH. This procedure applied to diphenyleneiodonium produced the same results as the above method. Stock solutions of the inhibitors were prepared in the following solvents: iodoniumdiphenyl nitrate (10mM) in 25% (v/v) ethanol; 2,2',4,4'-tetrachloroiodoniumdiphenyl chloride (10mM) in hot 50% (v/v) acetonitrile; 3,3'-dinitroiodoniumdiphenyl bisulphate (10mM) in 25% (v/v) ethanol; fluorene, dibenzofuran and dibenzothiophen (100 mM) in ethanol; dibenzothiophen sulphone (25 mM) in hot ethanol. Ethanol and acetonitrile in the amounts introduced with the inhibitors had no effect on enzyme rates.
Gel electrophoresis
After treatment with diphenylene[1251]iodonium as described above, 0.15 ml samples were treated with 20#1 of 10% (w/v) sodium dodecyl sulphate, 20,1 of 10% (v/v) 2-mercaptoethanol, 20,u1 of lM-sucrose and 2,ul of 0.4% Bromophenol Blue, and incubated at 100°C for 2min. For analysis of labelled polypeptides, samples contaning 150pg of protein in a volume of less than 150#1 were electrophoresed on 12cm x 6mm (internal diam.) gels containing 12.5% (w/v) acrylamide and 0.34 % bisacrylamide at 5.5 mA/ gel for 16h (Ragan, 1976a) , by the procedure of Weber & Osborn (1969) . Alternatively, samples were electrophoresed through a stacking gel into a running gel of the above composition, by using the buffer system J4179 of Jovin et al. (1971) as described by Neville & Glossmann (1974 
where n is the observed diphenyleneiodonium binding, N is the binding at saturation, D is the diphenyleneiodonium concentration and Kis a constant required to fit the data to a hyperbolic form. K has dimensions of molarity, but its meaning is more complex than a simple dissociation constant associaated with a binding phenomenon. The data were fitted by using an unweighted least-squares regression analysis (Wilkinson, 1961 (Ragan & Racker, 1973 ) (100nmol), soya-bean phosphatidylethanolamine (Ragan & Racker, 1973 ) (lOOnmol) and bovine heart cardiolipin (Sigma; 60nmol). Chromatograms were developed with solvents described in the text. After drying, spots were detected with iodine vapour. Radioactive spots were located with a radiochromatogram scanner.
Results
Inhibition of NADH-acceptor oxidoreductase activities of Complex I by diphenyleneiodonium
The inhibition by diphenyleneiodonium of NADH oxidation with a variety of electron acceptors is shown in Fig. 1 . NADH-ubiquinone-I oxidoreductase activity was the most susceptible to inhibition by diphenyleneiodonium. Oxidoreduction with K3Fe(CN)6 or juglone as acceptor was only slightly inhibited. Unexpectedly, menadione reduction was inhibited at diphenyleneiodonium concentrations similar to those required to inhibit ubiquinone reduction. This result contrasts with previous observations (Holland et al., 1973) in rat liver mitochondria, where menadione reduction was unaffected by diphenyleneiodonium. Further, this result illustrates that the mode of inhibition by diphenyleneiodonium differs from that of rotenone, which does not affect NADH-menadione oxidoreductase (Schatz & Racker, 1966 The inhibition of Complex I by diphenyleneiodonium was time-dependent (Fig. 2) . In this experiment, concentrations of diphenyleneiodonium sufficient to give eventual maximum inhibition were used (1 4M-diphenyleneiodonium was equivalent to 100nmol of diphenyleneiodonium/mg of Complex-I protein). A double-reciprocal plot of the apparent rate constants for inhibition versus diphenyleneiodonium concentration gave a straight line which intercepted at the origin (inset, Fig. 2 ). This is apparently consistent with a bimolecular reaction process (Kitz & Wilson, 1962) and the second-order rate constant was estimated to be 4.5 x105 M-1 * min-'.
The observation that such a clear-cut result was obtained may be deceptively simple and limited to the range of diphenyleneiodonium concentrations (1-4A4M) which had to be used to obtain substantial inhibition within the 2min duration of the assay, which were the conditions used in Fig. 2 .
Inhibition of NADH-ubiquinone-1 oxidoreductase activity by other iodonium compounds Inhibition of NADH-ubiquinone-1 oxidoreductase activity by structural analogues of diphenyleneiodonium Some compounds containing similar ring structure to diphenyleneiodonium were tested for inhibitory activity (Table 2) . Dibenzothiophen sulphone (I) was not inhibitory to NADH-ubiquinone-1 oxidoreductase at a concentration of 250pM. Higher concentrations were not used because of the extremely poor water solubility of this compound and the others in Table 2 . In order of increasing potency, fluorene (II), dibenzothiopen (III) and dibenzofuran (IV) all showed some inhibitory activity. Dibenzofuran at a concentration of 500pM caused 86 % inhibition of NADH-ubiquinone-1 oxidoreductase activity, but had little (10%) or no inhibitory effect on NADH-K3Fe(CN)6 and NADH-juglone oxidoreductase activities respectively. Dibenzofuran (100 1uM) also inhibited the NADH oxidase activity of submitochondrial particles by 50%. Succinate oxidase activity was inhibited, but required 4-5 times as much dibenzofuran for comparable inhibition. The inhibitory effects of dibenzofuran are therefore broadly similar to those of diphenyleneiodonium.
Binding of diphenyleneiodonium to the constituent polypeptides of Complex I
The superior potency of diphenyleneiodonium as an inhibitor of Complex I compared with structurally similar, but chemically unreactive, compounds such as dibenzofuran suggested the possibility that diphenyleneiodonium might be reacting covalently with some group on Complex I. This would be consistent with the susceptibility of this compound to nucleophilic attack, particularly in a non-polar environment (Banks, 1966) .
After treatment of Complex I with diphenylene-[1251]iodonium, significant amounts of radioactivity were associated with some of the constituent polypeptides after separation by gel electrophoresis in the presence of sodium dodecyl sulphate. Most of the radioactivity was associated with a polypeptide of mol.wt. 23500 (Fig. 3) . Lesser labelling of polypeptides of mol.wts. 75000, 53000, 42000, 33000 and 15500 was also evident, particularly at higher concentrations of diphenylene['25I]iodonium. As a routine, radioactivity determinations were performed on unstained gels, and radioactive peaks were identified with particular polypeptides by comparing electrophoretic mobilities with a parallel gel which had been stained. Stained gels had lost much of the radioactive label, but sufficient remained to confirm more directly the above identifications. Fig. 3 (Ragan, 1976a, and Fig. 4a) . A discontinuous system, running at pH9.5 (Jovin et al., 1971) , produced superior separations in this molecular-weight range, and the 23 500-mol.wt. polypeptide was clearly resolved (Fig. 4b) . Electrophoresis of labelled Complex I in this system confirmed that the 23500-mol.wt. polypeptide was the major labelled component. From the intensity of Coomassie Blue staining, the 23 500-mol.wt. polypeptide accounted for approx. 2.4% of the total protein, which, on the basis of 850000 for the protein molecular weight of Complex I (Ragan, 1976a) , is equivalent to 0.87mol of this polypeptide/ mol of Complex I (i.e. in all probability 1 mol of this polypeptide/mol of Complex I).
Fig . 5 shows the incorporation of radioactivity into the 23 500-mol.wt. polypeptide as a function of diphenylene[125I]iodonium concentration. In this experiment, the incorporation, extrapolated to infinite diphenyleneiodonium concentration, was 1.17 ± 0.10 (S.E.M., n = 6)nmol/mg of protein. This preparation of Complex I had an acid-extractable flavin content of 1.10nmol/mg. Thus the maximum incorporation of label into the polypeptide was 1.06±0.09 (S.E.M., n = 6)mol/mol of flavin. Six separate determinations of the stoicheiometry on two preparations of Complex I gave a value of 1.04 ± 0.05 (s.E.M.)mol/mol bf flavin. This stoicheiometry is readily explained by the assumption of 1mol of flavin/mol of Complex I (Ragan, 1976b) and 1 mol of the 23 500-mol.wt. polypeptide/mol of Complex I. The extent of covalent modification was also confirmed by using diphenylene['25I]iodonium of different specific radioactivities. If radioactive diphenyleneiodonium was diluted 4-fold with nonradioactive diphenyleneiodonium, the incorporation of label into Complex I was decreased by an equivalent amount. This confirms that the incorporation is due to diphenyleneiodonium and not an undetected contaminant.
The relationship between inhibition of ubiquinone reduction and radiochemical labelling of the 23 500-mol.wt. polypeptide is shown in Fig. 6 . 100% inhibition of the activity corresponded closely to the incorporation of 1 mol of inhibitor/mol of Complex I.
However, it is clear that there is not a linear relationship between inhibition and labelling. This observation is a major objection to the proposal that inhibition of enzyme activity is directly correlated with polypeptide labelling.
A contributing factor to this deviation from linearity may be instability of the covalent complex after dissociation of Complex I with sodium dodecyl sulphate. In the experiment of dissociation of Complex I were performed at different pH values, and after 6h the material was electrophoresed in the Weber & Osborn (1969) system at pH7.2. Despite the identical degree of inhibition of oxidoreduction in each case, the extent of labelling of the polypeptide was much less at pH7 than at pH 8 or 9, indicating dissociation of the label at more acid pH. Even at the optimum pH of 8, increasing the time delay between dissociation with sodium dodecyl sulphate and electrophoresis considerably decreased the extent of labelling of the 23 500-mol.wt. polypeptide (Table 3) . In all cases, changes in the degree of labelling of the 23 500-mol.wt. polypeptide were paralleled by changes in the labelling of the other polypeptides (Fig. 7) .
Despite the failure to show good correlation between the extent of inhibition of NADH-ubiquinone-1 oxidoreductase and the extent of labelling of the 23 500-mol.wt. polypeptide, it was clearly the only polypeptide to take up stoicheiometric quantities of inhibitor in the concentration range used. As shown in Fig. 1 , diphenyleneiodonium inhibited other activities of Complex I at higher concentrations of the inhibitor, and this may be related to the low labelling of other polypeptides, which was relatively more pronounced at higher concentrations of diphenylene[1251]iodonium.
Binding of diphenyleneiodonium to the phospholipids of Complex I
In view of the higher than stoicheiometric concentrations of diphenyleneiodonium required to inhibit Complex I, it is possible that the excess was binding to some other constituent, such as the phospholipids, which are present in large amounts relative to protein (Hatefi & Rieske, 1967) . Both Holland et al. (1973) and Gatley & Sherratt (1976) 1977 . Electrophoretic separation ofthe constituent polypeptides of Complex I Complex I (100,pg of protein) was dissociated with sodium dodecyl sulphate and electrophoresed (a) as described by Weber & Osborn (1969) or (b) as described by Neville & Glossman (1974) . Molecular weights (in thousands) in (a) were from Ragan (1976a) , or in (b) were redetermined by the same procedure. The two polypeptides of apparent mol.wt. 53 000 in (a) separate in (b) into a 53 000-and 49000-mol.wt. polypeptide. The 33 000-and 29000-mol.wt. polypeptides in (a) co-migrate with an apparent mol.wt. of 30000 in (b). The 26000-mol.wt. polypeptide in (a), which is scarcely resolved, is better separated in (b), with an apparent mol.wt. of 27000. Additional polypeptides in (b) which are not resolved in (a) are the 25000-and 16500-mol.wt. polypeptides. The arrows indicate the major labelled polypeptide in each system. (Ragan & Racker, 1973) , it also possible that the inhibitory effect of diphenyleneiodonium is due to some specific interaction with phospholipid, although the concentration of phos- polypeptide by diphenylene['25Iliodonium Complex I was labelled with diphenylene['l25]-iodonium (240nmol/mg of protein, specific radioactivity 11 460c.p.m./nmol) as described in the Materials and Methods section, except that the buffer was 0.1 M-sodium phosphate, pH7.0 (M), 0.1 M-Tris/ H2SO4, pH 8.0 (A), or 0.1 M-Tris/H2SO4, pH9.0 (-), After assay of NADH-ubiquinone-l oxidoreductase activity, samples containing 150pg of protein were electrophoresed on 12cm gels, starting 4h after addition of sodium dodecyl sulphate. Only that portion of the gel containing the 23 500-mol.wt. polypeptide was counted for radioactivity for the pH9.0 sample. For clarity, the graphs for the pH8 (A) and pH9 (-) samples are displaced vertically by 50 and 200c.p.m. respectively. Table 4 . T.l.c. ofphospholipids from Complex I labelled with diphenylene[1251]iodonium Lipid extracts and markers were prepared as described in the Materials and Methods section. Solvent systems were as described by Rouser & Fleischer (1967) . Abbreviations: PE, phosphatidylethanolamine; PC, phosphatidylcholine; CL,cardiolipin; DPI, diphenyleneiodonium.
RF values Solvent system Butan-1-ol/acetic acid/water (3:1:1, by vol). Chloroform/acetone/methanol/acetic acid/water (10: 4: 2: 2: 1, by vol.) Chloroform/methanol/aq. 28% (w/v) NH3 (13 (Hatefi & Stempel, 1967) . Certain subunits of Complex I are quantitatively solubilized (Ragan, 1976a) , but apparently not the 23 500-mol.wt. polypeptide. Moreover, the high-affinity inhibition site for rotenone is destroyed by chaotropic agents (Hatefi et al., 1969) .
After labelling Complex I with diphenylene['251]-iodonium (305nmol/mg of protein), 0.58mol/mol of flavin was found to be incorporated into the 23 500-mol.wt. polypeptide after analysis by gel electrophoresis. After treatment with 0.5 M-NaCIO4 for 10min at 30°C, this was slightly decreased to 0.50mol/mol of flavin. After separation of the soluble and particulate fractions by centrifugation (100 000g, 20min), the labelled polypeptide of mol.wt. 23500 was exclusively (48% of total recovery) located in the particulate fraction. The poor recovery can be attributed to dissociation of the label during centrifugation and resuspension of the particulate fraction. These results confirm that the major labelled polypeptide was not solubilized by chaotropic agents. In an experiment where diphenylene[1251]iodonium was added after resolution of Complex I by 0.5M-NaC1O4, incorporation of label was only 22 % of that found with unresolved Complex I.
Discussion
The original identification ofthe specific inhibitory action of diphenyleneiodonium on mitochondrial NADH oxidation showed that the inhibitor was very tightly bound to mitochondria (Holland et al., 1973) and the inhibitor could not be completely removed by serum albumin. This contrasts with rotenone which, although a more potent inhibitor, is displaced by this treatment (Horgan et al., 1968) . These observations indicated that diphenyleneiodonium might form a covalent bond with a constitutive component of the NADH dehydrogenase complex. Consideration ofthe chemistry of iodonium compounds suggests that this is quite feasible, since in non-polar solvents (i.e. benzene, dimethylformamide) diphenyleneiodonium may react with nucleophiles according to the sequence of reactions shown in Scheme 1 (Banks, 1966 (Table 3) .
The inhibitory action of diphenyleneiodonium on NADH-ubiquinone oxidoreductase activity shows a reasonable degree of specificity, and this is equally matched by the labelling of Complex I. Estimation of the amount of Coomassie Blue stain in the labelled polypeptide indicated that there is 1 mol of the labelled polypeptide/mol of Complex I. In addition, at saturating diphenyleneiodonium concentration, 1 mol of inhibitor is incorporated/mol of Complex I. The labelling of the 23 500-mol.wt. polypeptide is a highly specific reaction. Although other polypeptides are labelled by diphenyleneiodonium, they do not show equimolar stoicheiometry with the molar concentration of Complex I. In addition, the modification of the polypeptide is dependent on the structural integrity ofthe complex, since denaturation of Complex I with sodium dodecyl sulphate or resolution by chaotropic agents before treatment with diphenyleneiodonium both prevent incorporation into the 23 500-mol.wt. polypeptide.
Despite the specificity of the alkylation reaction, it is important to question whether the labelling reaction is directly connected with the inhibition of NADH dehydrogenase. With the present experimental data it is necessary to be highly critical of this connexion. However, we consider that the demonstration that complete inhibition of enzyme activity coincides with the incorporation of 1 mol of diphenyleneiodonium/ mol of Complex I is highly indicative of a relationship between these two events. The principal evidence against this proposal must be the non-linear relation between inhibition and binding (Fig. 6) . If the two events are related, then the non-linearity can only be accounted for by assuming that modification by diphenyleneiodonium induces a co-operative effect in the activity of NADH-ubiquinone oxidoreductase. Co-operativity in the binding of covalent inhibitors has been reported previously for much simpler systems. Rasool et al. (1976) showed that the modification of hexameric bovine liver glutamate dehydrogenase by 4-amino-6-chloro-5-oxohexanoic acid was active-site-directed and highly co-operative. A key requirement for co-operativity within Complex I is that the enzyme should exist in an oligomeric state in which catalytic subunits are linked. The basis for interaction of Complex-I molecules could be their existence as membranous aggregates in the absence of high concentrations of detergents. A similar explanation has been proposed to explain the behaviour of the Ca2+-dependent adenosine triphosphatase of sarcoplasmic reticulum, which exhibits negative co-operativity in the binding of either MgATP or MgADP (Yates & Duance, 1976) .
These arguments still leave the possibility that the modification ofthe 23 500-mol.wt. polypeptide is only indirectly connected with the inhibition of NADHubiquinone oxidoreductase activity. Thus diphenyleneiodonium might initially bind to a different region of Complex I which is responsible for inhibition. Subsequently, transfer to a hydrophobic region could result in covalent modification of the 23 500-mol.wt. polypeptide. Experimentally it has been observed that a number of polypeptides are slightly labelled by diphenyleneiodonium, which may merely reflect the fact that they are further from the primary binding site for diphenyleneiodonium.
The experiment with rotenone points out the fallacy of considering that a single polypeptide contains the binding characteristics for all the inhibitors of NADH-ubiquinone oxidoreductase. Since rotenone and diphenyleneiodonium are similar in their mode of inhibition of NADH-ubiquinone oxidoreductase, it would be expected that if there was a single binding peptide, then rotenone should prevent the binding of diphenyleneiodonium. Since this was not the case (Fig. 8) 
